Guardant Health
GH
#1175
Rank
C$28.19 B
Marketcap
C$212.64
Share price
-2.75%
Change (1 day)
200.32%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Market capitalization of Guardant Health (GH)

Market cap: C$28.19 Billion

As of June 2026 Guardant Health has a market cap of C$28.19 Billion. This makes Guardant Health the world's 1175th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Guardant Health from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026C$28.19 B53.94%
2025C$18.31 B239.37%
2024C$5.39 B23.93%
2023C$4.35 B15.18%
2022C$3.78 B-70.82%
2021C$12.95 B-21.12%
2020C$16.42 B71.42%
2019C$9.58 B118.25%
2018C$4.39 B

End of Day market cap according to different sources

On Jun 29th, 2026 the market cap of Guardant Health was reported to be:

C$28.99 Billion
by Nasdaq info icon info icon
C$28.99 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Neogen
NEOG
C$2.75 B-90.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
C$55.18 B 95.71%๐Ÿ‡บ๐Ÿ‡ธ USA